Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 9/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.54 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.51 |
| ▸ | METAP2 | P50579 | 1/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.49 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28750838 | 0.80 | ASIC3 (0.53) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL21128574 | 0.79 | IDO1 (0.74) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL872414 | 0.78 | IDO1 (1.00) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL872416 | 0.78 | IDO1 (1.00) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL25214286 | 0.78 | IDO1 (0.64) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL25262025 | 0.78 | IDO1 (0.64) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL1949479 | 0.78 | IDO1 (1.00) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL1502406 | 0.78 | IDO1 (0.64) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL871045 | 0.77 | IDO1 (0.58) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 | |
| SCHEMBL14340642 | 0.77 | IDO1 (0.58) | IDO1CYP3A4CYP2E1CYP2D6CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109890805-B | Substituted azole derivatives for the production, proliferation and differentiation of hematopoietic stem and progenitor cells | 新加坡国立大学 | 2023-04-04 | — | — | CN | disclosed |
| WO-2023022497-A1 | SOS1 INHIBITOR AND USE THEREOF | 주식회사 카나프테라퓨틱스 | 2023-02-23 | — | — | WO | disclosed |
| EP-3032625-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2020-01-08 | — | — | EP | disclosed |
| CN-107614497-A | novel corrosion inhibitor | 艺康美国股份有限公司 | 2018-01-19 | — | — | CN | disclosed |
| EP-3264506-A1 | METHOD FOR PRODUCING A FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2018-01-03 | — | — | EP | disclosed |
| EP-2458667-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2017-05-24 | — | — | EP | disclosed |
| EP-2763223-B1 | POROUS SEPARATOR FOR FUEL CELLS | NISSHINBO CHEMICAL INC (JP) | 2016-11-16 | — | — | EP | disclosed |
| EP-3032625-A1 | FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2016-06-15 | — | — | EP | disclosed |
| US-20160156044-A1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC. (JP) | 2016-06-02 | — | — | US | disclosed |
| US-9174942-B2 | IDO inhibitors | NEWLINK GENETICS CORPORATION (US) | 2015-11-03 | — | — | US | disclosed |
| EP-2763223-A1 | POROUS SEPARATOR FOR FUEL CELLS | Nisshinbo Chemical Inc. (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-8748469-B2 | IDO inhibitors | NEWLINK GENETICS CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| CN-102083429-B | Ido inhibitors | NEWLINK GENETICS | 2014-05-28 | — | — | CN | disclosed |
| US-8372192-B2 | Fuel cell separator | NISSHINBO CHEMICAL INC. (JP) | 2013-02-12 | — | — | US | disclosed |
| EP-2458667-A1 | FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20120077111-A1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC. (JP) | 2012-03-29 | — | — | US | disclosed |
| US-20110136796-A1 | IDO Inhibitors | NEWLINK GENETICS (US) | 2011-06-09 | — | — | US | disclosed |
| CN-102083429-A | Ido inhibitors | NEWLINK GENETICS | 2011-06-01 | — | — | CN | disclosed |
| EP-2291187-A2 | IDO INHIBITORS | Newlink Genetics (US) | 2011-03-09 | — | — | EP | disclosed |
| WO-2009132238-A2 | IDO INHIBITORS | NEWLINK GENETICS (US) | 2009-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136796-A1 | IDO Inhibitors | IDO1, IDO2, INMT | IDO1 1/4885CYP3A4 250/4885CYP2E1 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.